- Iowa hospital CEO to retire
- The biggest gap in OR performance — and how to address it
- Hospital primary palliative care linked to lower ICU admission, length of stay: 4 notes
- The Clinical Denial Surge: Why Your Business Office Needs an Artificial Intelligence “Clinician-Attorney” Hybrid
- CHS to sell 9 hospitals for more than $1.2B
- Medical City Alliance taps new COO
- Cencora acquires EyeSouth Partners’ retina arm for $1.1B
- FDA to hold public hearing on drug voucher pilot
- Providence saves $2.3M through device reuse strategy
- 3 contenders for CDC’s top spot: Reports
- Where the ACA stands, 16 years in
- Where the ACA stands, 16 years in
- Children’s National launches division for pediatric AI research
- Best small cities for careers
- Orthopedic ASC proposed in Massachusetts
- Sutter-Allina deal pushes ambulatory growth strategy
- FTC launches healthcare task force
- Nearly 90,000 Bottles of Children’s Ibuprofen Recalled Nationwide
- Meet the CEOs, presidents leading the largest ASC companies
- Algunos adultos de mediana edad deciden posponer la atención médica hasta tener Medicare
- ¿Qué tan bajo se puede llegar? Las cambiantes guías para el control de la presión arterial
- A Nasal Swab for Alzheimer's? Duke Team Has One in Testing
- Your Bank Account Might Show How Well Your Brain Will Age, Researchers Say
- Rural Residents Have Highest Cancer Death Rates, Researchers Say
- Insurance Lapses Play Havoc With Diabetes Management, Study Shows
- Psychedelics Aren't Better Than Antidepressants In Treating Depression, Review Concludes
- Heat Advisories Might Not Trigger Soon Enough For Some Seniors, Study Finds
- Dizal's Zegfrovy clinches landmark phase 3 win in NSCLC subtype, setting up challenge to J&J's Rybrevant
- Novartis joins Lilly, AZ in China expansion with $480M commitment to boost manufacturing, R&D
- Rising Health Costs Push Some Middle-Aged Adults To Skip the Doc Until Medicare
- Even With Dental Insurance, You Still Could Face a Large Bill
- FDA solicits feedback on controversial national priority voucher review pathway
- Health Tech Weekly Rundown: Perplexity rolls out AI-powered medical records search; Doximity survey examines how docs use AI
- Don't Forget This: Study Shows Cannabis Exacts a Toll on Your Memory
- Want To Stress Less? Start With These Everyday Habits
- Journalists Shine Light on Out-of-Reach Insurance Prices, AI’s Role in Claims Disputes, and Susie Wiles
- Arizona behavioral health center adds 10 adolescent beds
- The explosion of the Medicare Advantage special needs plan
- North Star to cut additional jobs
- 6 Optum updates to know from Q1
- The shifting dental hygiene landscape
- 12 dental insurance updates in 30 days
- ‘The 1980s called’: CMS to phase out fax, mail
- This ASC startup is wiring AI into the fabric of outpatient surgery
- Springer Nature retracts 38 papers over autism dataset
- Intermountain plans new outpatient clinic
- Legacy Health, Regence BCBS face looming contract expiration
- Meet the COOs of the largest DSOs
- In the Affordability Alphabet Soup of the ACA and EHBs, a Link to Higher Premiums Isn’t Clear-Cut
- New York organizations partner on intellectual, developmental disabilities campus
- CMS final rule aims to axe the fax machine, phase out paper mailing
- 24 profitable health systems in 2025
- How 2 CFOs plan for uncertainty
- Heartland Dental expands with Texas affiliation
- SALT Dental Partners adds Washington practice
- 11 dental school updates to know
- 6 health systems seeking revenue cycle executive directors
- Remarks at The SEC Speaks in 2026: From Kitchen Table to Cap Table—Making Capital Formation Work for Small Businesses
- Integrated care model drives 76% depression improvement in 44 days: Study
- Heart Benefits From GLP-1 Drugs Fade After Stopping, Study Finds
- Survey Shows More People Struggling To Afford ACA Insurance
- Up to 155,000 COVID Deaths May Not Have Been Counted, Study Finds
- FDA Drops Plan To Ban Tanning Beds for Minors Nationwide
- Idaho bill proposes consolidating dental regulatory oversight
- Washington hospital charts path to preserve primary care
- 4 DSOs making headlines
- 6 state behavioral health policy updates
- 80% of returning ACA enrollees report higher healthcare costs in 2026
- NYC Health + Hospitals names dentistry, oral surgery leaders
- Mindray North America Enters Ventilator Market
- Mindray North America Enters Ventilator Market
- LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea
- LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea
- Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
- Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
- EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization
- EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization
- With Novo's semaglutide going off patent, Indian drugmakers set to launch their cheaper generics
- Sanofi backs 2 more documentary films about rare blood disorders
- ACIP member's miscommunication on vaccine panel's future adds to confusion after court ruling
- Rhythm's Imcivree scores 'transformative' FDA approval in brain damage-related obesity
- Some Patients With ADHD and Addiction History Missing Out
- Social Media Poses Risks to Children's Mental Health, Review Concludes
- Does Closing Your Eyes Help You Hear Better?
- 'Early Bird' Exercisers Get The Most Health Benefits, Study Finds
- High Blood Pressure Deaths Quadruple Among Young Women, Study Finds
- Meningitis Vaccine Doesn't Protect Gay, Bisexual Men From Gonorrhea, Clinical Trial Concludes
- Oz Escalates Medicaid Fraud Claims Against States After Focus on Minnesota
- ‘How Low Can You Go?’ The Shifting Guidelines for Blood Pressure Control
- Listen: Trump’s NIH ‘Reset’ Is Driving Away Scientists
- Mississippi to fund clinical trials for psychedelic drug
- Lawmakers push bill to boost mental health workforce, diversity
- Florida State partners with behavioral health provider on research
- Utah governor signs hygienist autonomy bill
- UHS CEO: Talkspace deal builds 1st national ‘end-to-end’ behavioral model
- Psychedelic therapy shows no benefit over antidepressants: Study
- What the Health? From KFF Health News: RFK Jr.’s Vaccine Schedule Changes Blocked — For Now
- Verily banks $300M to accelerate AI road map, transitions to independent company
- KFF: ACA plan enrollees report rising costs for 2026 coverage
- Industry Voices—Stop buying AI tools, start designing AI architecture
- CSL warns of supply shortfall, treatment delays for hemophilia gene therapy Hemgenix
- 10K Corewell Health nurses vote to authorize labor strike
- Providence mulling sale of its health plan amid financial pressures
- Fierce Pharma Asia—World's 1st brain chip nod; AZ's cell therapy bet; Astellas-CytomX breakup
- Gut Microbiome May Take Years to Recover From Antibiotic Use
- Prepared Remarks Before SEC Speaks
- The Art and Science of Materiality
- Capital, Choice, and the Pursuit of Happiness: Remarks at The SEC Speaks in 2026
- Novo's Wegovy HD passes muster under FDA national priority voucher program
- Hospital operations begin 2026 with depressed margins amid low volumes, high labor spend
- The Math Behind Eczema Flare-Ups May Finally Add Up
- Male preconception startup Upstream announces donor-matching platform
- Women's health sector could grow to $600B industry by 2030: PwC report
- Democratic senators detail plans to take on 'Big Insurance'
- PrescriberPoint's solution to the modern prescribing journey
- Both Types Of Diabetes Increase Dementia Risk
- Aldi Recalls Spinach Bites Over Possible Contamination
- Collegium ponies up $650M to gain ADHD drug Azstarys from Corium
- Maryland bill calls for more transparency in pharma's disease awareness campaigns
- After Alfasigma's GSK licensing deal, Lynavoy picks up FDA nod in rare liver disease
- What To Know About Fatty Liver Disease and Why It’s So Common
- Drug Smoking Linked To Surge In Severe Burn Cases
- Thymus Gland Health May Be Key to Long Life and Fighting Cancer
- Premature Menopause Increases Heart Disease Risk
- U.S. Teen Obesity Hits Record Highs While Efforts to Slim Down Drop
- Pesticide Exposure Before Pregnancy Might Risk Newborn Health
- UPDATED: AstraZeneca to build cell therapy manufacturing hub, R&D center in Shanghai
- How CVS Caremark Is Shaping the Future of Pharmacy Benefits
- CDMO Axplora to pump $60M into Italian complex API plant
- Pfizer eyes earlier Talzenna use after phase 3 prostate cancer win
- Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia
- Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia
- JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)
- JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)
- Turquoise Health raises $40M to power healthcare contracts, payments
- To tackle healthcare costs, representatives weigh curbs on provider consolidation
- A look at Highmark's specialty pharmacy partnership with Free Market Health
- AD/PD 2026: New data highlight potential cost-effectiveness of confirmatory AD blood testing in U.S. diagnostic pathways
- With downgrade, HSBC casts doubt about Lilly's 'stairway to heaven' trajectory
- TrumpRx's 'world's lowest' drug price claims fall short in global comparison: NYT
- Beyond payment integrity: An AI-driven approach to affordability
- Study Finds Little Proof Cannabis Helps Most Mental Health Conditions
- Meningitis Outbreak Tied to Students Leaves 2 Dead and 11 Sick in England
- J&J, Protagonist's 'game-changer' once-daily psoriasis pill Icotyde nabs FDA approval
- Belly Fat Linked To Heart Failure Risk
- Women More Likely To Survive Cancer Than Men — At A Cost
- BMS brings 'Emily in Paris' star and cancer survivor Ashley Park aboard campaign honoring oncologists
- healow Genie AI Contact Center Helped Manage 76% of Calls—Demonstrating That Patient Access and Operational Efficiency Go Together
- Sandoz expands biosim collab with Samsung Bioepis, sets sights on Takeda's Entyvio
- Ultra-Processed Foods Linked To Heart Attack, Stroke, Cardiac Arrest
Michigan's own Saul Anunzis wants you to know that the flat rate the Centers for Medicare and Medicaid Services (CMS) proposed for Medicare Advantage plans in 2027 will squeeze the lifeblood out of these popular programs:
Stop the Medicare Advantage Squeeze Before Seniors Pay the Price
By Saul Anuzis - February 26, 2026In a federal system riddled with inefficiency, Medicare Advantage stands out as a rare success story protecting the wallet and improving the health of 35 million seniors and people with disabilities who rely on it.
Congress created Medicare Advantage in 1997 to improve healthcare for seniors and control spending through market forces. Today more than half of America’s seniors rely on it. Public polling consistently shows satisfaction rates with Medicare Advantage hovering around 95 percent. That success story is now at risk.
At the beginning of each year, the government publishes its advanced rate notice on how much it will invest in Medicare Advantage plans the following year. Last month the Centers for Medicare and Medicaid Services (CMS) proposed a nearly flat rate for Medicare Advantage plans in 2027. This amounts to a massive cut since national health care spending rose by 7.2 percent in 2024 and is projected to grow another 7.1 percent in 2025. When payments lag this far behind actual medical cost growth, the shortfall shows up in higher premiums, reduced benefits, and fewer plan choices for seniors.
We’ve already seen what happens when Washington squeezes this program. The Biden administration cut Medicare Advantage funding by roughly $130 billion over two years, triggering predictable results: plans trimmed supplemental benefits, increased cost-sharing, narrowed provider networks, and in some cases exited markets entirely. The program has little capacity left to absorb another effective cut without exacerbating the turbulence driven by Biden‑era cuts – ultimately leaving seniors to face a crisis of shrinking choices and eroding benefits.
Benefits that matter deeply to seniors – hearing aids, dental care, transportation to appointments, gym memberships, meal services – are often the first to go when plans are forced to cut.
Smaller, regional, and innovative plans are hit hardest by abrupt payment shifts. Large national carriers may be able to absorb volatility. Local plans cannot. The result is consolidation, reduced competition, and fewer tailored options for seniors, especially in rural and underserved communities.
And remember: seniors are uniquely vulnerable to inflation. Younger workers eventually see wages adjust. Seniors on fixed incomes and families who support them do not. Cutting coverage for seniors under these circumstances is especially indefensible, because the program has been a stable, predictable cost while everything else has become more expensive as a direct result of inflation driven by Washington’s excessive spending and money‑printing under Biden.
But, for Democrats, the turmoil is the point. There’s no bigger threat to the socialist healthcare-for-all fantasy than a stable and competitive free market alternative. Republicans should not fall into their trap of making Medicare Advantage a scapegoat for the failures of socialized healthcare.
There is also a political reality here that Republicans ignore at their peril. Medicare Advantage open enrollment begins in mid-October. If seniors receive notices weeks before an election informing them that their premiums are rising, their networks are shrinking, or their dental benefits are disappearing, they will blame the party in charge.
The Trump administration has repeatedly pledged to both protect and strengthen Medicare. That commitment helped build trust with older voters who value stability and results. The Make America Healthy Again (MAHA) agenda focuses on tackling the real cost drivers in health care – from excessive hospital pricing to skyrocketing prescription drug costs – while incentivizing prevention and healthier living. Undermining Medicare Advantage now risks squandering those gains.
We should be strengthening what works, not destabilizing it. Modernization and oversight are appropriate. Risk adjustment formulas can be refined. Fraud and abuse should always be addressed. But cutting Medicare Advantage won’t solve these challenges – it will erode the very market incentives that drive better outcomes for 35 million American seniors.
By adjusting the 2027 rate to reflect real-world medical cost growth, President Trump has an opportunity to send a clear message to our nation’s seniors. Republicans in Congress should make the case directly to the White House and to CMS. Seniors and caregivers should make their voices heard with their elected representatives. Now is the time for all stakeholders to speak up.
Seniors chose Medicare Advantage because it delivers value, security, and dignity. They made America great - working, paying taxes, and defending our freedoms abroad. Washington should not upend the mechanisms that keep them healthy.
Saul Anuzis is the president of the 60 Plus Association.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














